UMKC Innovation Center partners with the university and the community to spark and sustain entrepreneurial efforts within our region and across the country.

KCSourceLink connects KC entrepreneurs to the right resource at the right time.

MOSourceLink connects Missouri entrepreneurs to the right resource at the right time.

Whiteboard2Boardroom connects entrepreneurs and businesses to technologies available for licensing.

Digital Sandbox KC provides early-stage proof-of-concept support for digital products.

Missouri Small Business & Technology Development Center provides technical assistance to startup and existing businesses.

ScaleUP! Kansas City helps businesses with revenues around $200K scale toward their first $1 million.

Missouri Procurement Technical Assistance Centers helps local businesses obtain government contracts.

KCInvestED helps investors learn more about investing in KC startups.

SourceLink® helps communities nationwide build vibrant and vital entrepreneurial ecosystems.
UMKC Innovation Center
View Other Classes & Events

Healthcare Innovation: What’s Next for the Angel Investor

Wednesday, September 14 @ 11:00 am - 12:00 pm • Organized By Angel Capital Association
Online Event


This webinar will cover a wide range of topics related to the investing in a healthcare startup and features an incredible member of the angel community, Dr. David Gershon.
Webinar objectives will be:

To increase awareness about how healthcare start-ups are driven by scientific breakthroughs to deliver better healthcare to patients.
To break down barriers that investors have to healthcare investment including understanding the technical/scientific complexities, regulations and IP.
To define the potential ROI in healthcare investing, while simultaneously mitigating risk.
Dr. David Martin Gershon is the Founder of Gershon Capital and the Managing Partner of the Endeavor Life Sciences Venture Fund I and II, investing in great entrepreneurs and life science companies that possess innovative technologies and strong commercial potential. 

Dr. Gershon has 20 years of experience as a neuroscientist, oncologist/immunologist, healthcare economist, and FDA healthcare regulatory attorney, with expertise in drug and device approval processes, clinical research, and pricing and reimbursement. 

Amongst his accomplishments Dr. Gershon is a Standard & Poor’s Healthcare Industry Leader, former Chairman of the Aspen Institute Business of Health Program, Aspen Institute Senior Fellow, and Memorial Sloan-Kettering Cancer Center Mayday Fellow and has been a Senior Advisor to McKinsey & Co., Goldman Sachs, Bain Capital, Texas Pacific Group, GlaxoSmithKline, Bristol-Myers Squibb, Pfizer, Novartis, BlackRock, Caxton Associates, Pictet Group, Merrill Lynch, UBS, SG Cowen, Tiger Global, Fidelity Investments, the William J. Clinton Foundation, the Federal Reserve Board of Governors, and the Rockefeller Foundation. 

Dr. Gershon has been featured as a leading expert in healthcare and life science investment on CNBC and has been a speaker at numerous conferences including the Harvard Business School Health Industry Alumni Conference, and is an Adjunct Professor of Healthcare Economics and Policy at Johns Hopkins University, Guest Lecturer of Healthcare Finance abd Drug Development at Harvard University and MIT Sloan Business School, Assistant Professor of Healthcare Economics and Finance at Columbia University, Visiting Scholar Lecturer of Healthcare Economics and Policy at McGill University, Advisor in Entrepreneurship to the NYU Stern School of Business, Berkeley Center for Entrepreneurial Studies, Columbia University School of Business, Eugene M. Lang Center for Entrepreneurship, and Harvard Innovation Labs.
Angel Capital Association
Angel Capital Association
(913) 894-4700
September 14 @ 11:00 am - 12:00 pm Add to my Calendar
Add event to: ICal Outlook Google Calendar
Online Event